Wealth Plan Partners, LLC Amgen Inc Transaction History

Wealth Plan Partners, LLC

$745 Billion
Q3 2024

A detailed history of Wealth Plan Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wealth Plan Partners, LLC holds 13,931 shares of AMGN stock, worth $3.67 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

13,931

Previous 12,337 12.92%

Holding current value

$3.67 Million

Previous $3.85 Billion 16.45%

% of portfolio

0.6%

Previous 0.41%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$309.38 - $337.38 $493,151 - $537,783	1,594 Added 12.92%	13,931 $4.49 Billion
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $3.24 Million - $3.94 Million	12,337 New	12,337 $3.85 Billion
Q4 2023 Jan 05, 2024	SELL	$255.7 - $288.46 $6,136 - $6,923	-24 Reduced 2.86%	816 $235 Million
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $13,556 - $16,830	62 Added 7.97%	840 $226 Million
Q2 2023 Jul 31, 2023	SELL	$214.27 - $253.37 $2,356 - $2,787	-11 Reduced 1.39%	778 $173 Million
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $1.08 Million - $1.31 Million	-4,773 Reduced 85.81%	789 $191 Million
Q4 2022 Feb 16, 2023	BUY	$229.03 - $291.01 $2,977 - $3,783	13 Added 0.23%	5,562 $1.34 Billion
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $13,814 - $15,281	63 Added 1.15%	5,549 $1.29 Million
Q4 2021 Feb 01, 2022	BUY	$198.88 - $227.6 $4,574 - $5,234	23 Added 0.42%	5,486 $1.25 Million
Q3 2021 Dec 09, 2021	SELL	$212.27 - $248.7 $47,973 - $56,206	-226 Reduced 3.97%	5,463 $1.16 Million
Q2 2021 Aug 19, 2021	BUY	$233.58 - $259.14 $6,073 - $6,737	26 Added 0.46%	5,689 $1.3 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $219,025 - $255,238	-987 Reduced 14.84%	5,663 $1.4 Million
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $2,596 - $3,092	-12 Reduced 0.18%	6,650 $1.58 Million
Q3 2020 Dec 18, 2020	BUY	$234.65 - $260.95 $4,458 - $4,958	19 Added 0.29%	6,662 $1.58 Million
Q2 2020 Aug 19, 2020	BUY	$197.81 - $242.74 $469,996 - $576,750	2,376 Added 55.68%	6,643 $1.6 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $7,654 - $10,151	-42 Reduced 0.97%	4,267 $1.02 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $72,089 - $92,659	-381 Reduced 8.12%	4,309 $979,000
Q3 2019 Nov 15, 2019	SELL	$174.11 - $208.62 $126,055 - $151,040	-724 Reduced 13.37%	4,690 $1.03 Million
Q2 2019 Aug 19, 2019	BUY	$166.7 - $195.41 $164,866 - $193,260	989 Added 22.35%	5,414 $1.12 Million
Q1 2019 May 16, 2019	SELL	$180.87 - $203.88 $78,859 - $88,891	-436 Reduced 8.97%	4,425 $751,000
Q4 2018 Feb 20, 2019	SELL	$178.4 - $208.25 $184,287 - $215,122	-1,033 Reduced 17.53%	4,861 $915,000
Q3 2018 Nov 21, 2018	SELL	$185.29 - $208.89 $113,953 - $128,467	-615 Reduced 9.45%	5,894 $1.16 Million
Q2 2018 Aug 16, 2018	BUY	$166.05 - $186.51 $281,620 - $316,320	1,696 Added 35.24%	6,509 $1.2 Million
Q1 2018 May 16, 2018	BUY	$169.43 - $198.0 $815,466 - $952,974	4,813 New	4,813 $821,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Plan Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Plan Partners, LLC with notifications on news.

Account

Wealth Plan Partners, LLC Amgen Inc Transaction History